Simeni Njonnou Sylvain Raoul, Noumedem Anangmo Nadia Christelle, Kemta Lekpa Fernando, Noukeu Njinkui Diomede, Enyama Dominique, Ngongang Ouankou Christian, Vounsia Balti Eric, Mbono Samba Eloumba Esther Astrid, Moulion Tapouh Jean Roger, Choukem Simeon Pierre
Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon.
Interdiscip Perspect Infect Dis. 2021 Oct 12;2021:4258414. doi: 10.1155/2021/4258414. eCollection 2021.
Despite some cases of severe or critical manifestations of the coronavirus disease 2019 (COVID-19) described among children, the prevalence of this infection in the pediatric population is quite low worldwide, particularly in sub-Saharan Africa. Current data suggest indeed that, independent of the population considered overall, severe and critical cases of COVID-19 are rare among children. This observation prompted us to discuss the possible hypotheses which could explain the low prevalence of COVID-19 among children; amongst others, we discuss (1) immunomodulation by the Bacillus Calmette-Guerin vaccine or by some parasitic infections such as malaria, schistosomiasis, and helminthiasis and (2) cross immunization with other coronaviruses commonly found in the sub-Saharan African setting.
尽管在儿童中出现了一些2019冠状病毒病(COVID-19)的严重或危重症表现病例,但在全球范围内,这种感染在儿科人群中的流行率相当低,特别是在撒哈拉以南非洲地区。目前的数据确实表明,无论总体上考虑的人群如何,COVID-19的重症和危重症病例在儿童中都很罕见。这一观察结果促使我们讨论可能解释COVID-19在儿童中低流行率的假设;其中,我们讨论了(1)卡介苗疫苗或某些寄生虫感染(如疟疾、血吸虫病和蠕虫病)的免疫调节作用,以及(2)与撒哈拉以南非洲地区常见的其他冠状病毒的交叉免疫。